Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.
about
Novel sunitinib strategy in metastatic renal cell carcinoma on hemodialysis: intermittent dose of sunitinib after hemodialysisIntolerance to sunitinib treatment in hemodialysis patients with metastatic renal cell carcinomaFeasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience.Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.
P2860
Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.
@en
Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.
@nl
type
label
Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.
@en
Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.
@nl
prefLabel
Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.
@en
Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.
@nl
P2093
P1433
P1476
Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.
@en
P2093
Ivan Platzek
Manfred P Wirth
Michael Froehner
Stefan Zastrow
Vladimir Novotny
P304
P356
10.1016/J.UROLOGY.2008.10.028
P407
P577
2009-01-23T00:00:00Z